3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Breast
1
Conditions
Solid Tumors
1
Interventions
atezolizumab
3
Docetaxel
3
pembrolizumab
2
olaparib
2
lenvatinib
2
Leucovorin
2
Irinotecan
2
Immune Checkpoint Inhibitors
2
Fluorouracil
2
Filgrastim
2
Capecitabine
2
zolbetuximab
1
tomivosertib
1
spartalizumab
1
somatostatin receptor 2
1
pralsetinib
1
pegylated granulocyte colony-stimulating factor
1
necitumumab
1
motesanib diphosphate
1
ipatasertib
1
inavolisib
1
entrectinib
1
ensartinib
1
dapagliflozin
1
cobimetinib
1
cemiplimab
1
cat's claw extract
1
balugrastim
1
anlotinib
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Solid Tumors
×
somatostatin receptor 2
×
Clear all
NCT07178938
2025-11-14
THERANOVA
MedSIR
Phase 2
Not yet recruiting
10 enrolled